The effect of prostaglandins on hypothalamic L-cystine arylamidase activity and on luteinizing hormone secretion in the rat.
D000626:Aminopeptidases / Q000378:metabolism*; D000818:Animals; D001241:Aspirin / Q000494:pharmacology; D003553:Cystine; D004031:Diestrus; D004305:Dose-Response Relationship, Drug; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D007031:Hypothalamus / Q000201:enzymology*; D007275:Injections, Intravenous; D007986:Luteinizing Hormone / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology; D008297:Male; D010053:Ovary / Q000502:physiology; D010902:Pituitary Gland / Q000378:metabolism*; D010903:Pituitary Gland, Anterior / Q000378:metabolism*; D011247:Pregnancy; D011453:Prostaglandins / Q000494:pharmacology*; D011454:Prostaglandins A / Q000008:administration & dosage / Q000494:pharmacology; D011458:Prostaglandins E / Q000008:administration & dosage / Q000494:pharmacology; D011460:Prostaglandins F / Q000008:administration & dosage / Q000494:pharmacology; D051381:Rats; D013997:Time Factors
D011453:Prostaglandins; D011454:Prostaglandins A; D011458:Prostaglandins E; D011460:Prostaglandins F; D003553:Cystine; D004958:Estradiol; D007986:Luteinizing Hormone; D000626:Aminopeptidases; D001241:Aspirin